Molecular diagnostics is a way of performing a diagnostic test to discover ailment, circumstance or infection in an artificial surroundings. Molecular diagnostic is one of the principal segments of in-vitro diagnostics marketplace. Molecular diagnostics is used to measure and stumble on the presence of genetic fabric related to specific disorder. It is used to identify DNA and RNA at molecular stage. Molecular diagnostics is a device to improve clinical effects and clinical decisions. Molecular diagnostic consists of all exams used to become aware of a disorder, by analyzing molecules such as DNA, protein or RNA in a fluid or tissue. In recent times molecular diagnostics is utilized in early detection of infectious sicknesses, most cancers and genetic ailment, by way of the usage of molecular and genetic technologies. Molecular diagnostics is likewise utilized in detection of abnormalities in pre-natal stage. Further, molecular diagnostic kits are utilized in pharmacogenetics trying out and blood donor screening.
How Big is the Global Molecular Diagnostics Market?
The Global Molecular Diagnostics Market is expected to be around US$ 17.10 billion by 2028 and will grow at a CAGR of more than 9% in the given forecast period.
The major driving factors of Global Molecular Diagnostics Market are as follows:
• Increasing application in blood screening
• Increasing prevalence of chronic and infectious diseases such as HIV and hepatitis
• Rising awareness and acceptance of personalized medicine
The restraining factors of Global Molecular Diagnostics Market are as follows:
• Require more time for approval of many new molecular diagnostic tests
• Changing reimbursement regulations
The Global Molecular Diagnostics Market is segmented on the lines of its application, technology, product, end user and regional. Based on application segmentation it covers infectious diseases, genetics, oncology, microbiology, blood screening and others. Under technology segmentation it covers polymerase chain reaction, hybridization, isothermal nucleic acid amplification technology, microarrays, DNA sequencing and next generation sequencing and others. The molecular diagnostics market is segmented on the lines of its product into reagents, instruments and services & software. Based on end user segmentation it covers hospital laboratories, reference laboratories and others. The molecular diagnostics market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the Global Molecular Diagnostics Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Molecular Diagnostics Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Global Molecular Diagnostics Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include F. Hoffmann-La Roche Ltd, Cepheid, Abbott Molecular, Bio-Rad Laboratories, Inc., Johnson & Johnson Services, Inc., Dako, Alere, Inc., Novartis AG, Siemens Healthcare, Bayer AG, Hologic, Inc. (Gen Probe), Becton, Dickinson and Company, Sysmex Corporation, bioMérieux SA, Danaher Corporation, and Qiagen.Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Molecular Diagnostics Market has been segmented as below:
By Application Analysis
Infectious Diseases
Genetics
Oncology
Microbiology
Blood Screening
Others
By Product Analysis
Instruments
Reagents
Services & Software
By Technology Analysis
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Hybridization
DNA Sequencing and Next-generation Sequencing
Microarrays
Others (Mass Spectrometry, Flow Cytometry, and Electrophoresis)
By End-user Analysis
Hospital Laboratories
Reference Laboratories
Others
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Molecular Diagnostics Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Molecular Diagnostics Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Computed Tomography Devices Market
Continuous Peripheral Nerve Block Catheter Market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions
3 Executive Summary
3.1 Introduction
3.2 Conclusion
4 Premium Insights
4.1 Molecular Diagnostics: Market Overview
4.2 Molecular Diagnostics Market Size, By Type of Infectious Disease, 2018 vs 2024
4.3 Market, By Technology and Application
4.4 Market Size, By End User, 2018 vs 2024
4.5 Market Size, By Product and Service, 2018 vs 2024
4.6 Geographic Growth Opportunities
5 Molecular Diagnostics Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Prevalence of Infectious Diseases and Various Types of Cancer
5.2.1.2 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
5.2.1.3 Growth in the Biomarker Identification Market and Advancements in Molecular Techniques
5.2.1.4 Reforms in the Reimbursement System in the U.S.
5.2.2 Restraints
5.2.2.1 Complex Regulatory Frameworks to Delay Approvals of New Molecular Diagnostic Tests
5.2.3 Opportunities
5.2.3.1 Advances in Genomics and Proteomics
5.2.3.2 Increasing Adoption of Point-Of-Care Testing
5.2.3.3 Significant Growth Prospects in Developing Countries
5.2.4 Challenge
5.2.4.1 Dearth of Trained Professionals Limiting the Appropriate Use of New Molecular Diagnostic Technologies
6 Molecular Diagnostics Market, By Application
6.1 Introduction
6.2 Infectious Diseases
6.2.1 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.2.2 Hepatitis B
6.2.3 Human Papillomavirus (HPV)
6.2.4 Human Immunodeficiency Virus (HIV)
6.2.5 Tuberculosis (TB)
6.2.6 Hepatitis C
6.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.2.8 Other Infectious Diseases
6.3 Oncology
6.3.1 Breast Cancer
6.3.2 Colorectal Cancer
6.3.3 Prostate Cancer
6.3.4 Other Cancers
6.4 Blood Screening
6.5 Genetic Tests
6.6 Microbiology
6.7 Other Applications
7 Molecular Diagnostics Market, By Technology
7.1 Introduction
7.2 Polymerase Chain Reaction (PCR)
7.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.4 Hybridization (In-Situ Hybridization & Fish)
7.5 DNA Sequencing and Next-Generation Sequencing
7.6 Microarray
7.7 Other Technologies
8 Molecular Diagnostics Market, By Products and Services
8.1 Introduction
8.2 Reagents & Kits
8.3 Instruments
8.4 Software & Services
9 Molecular Diagnostics Market, By End User
9.1 Introduction
9.2 Hospital and Academic Laboratories
9.3 Reference Laboratories
9.4 Other End Users
10 Molecular Diagnostics Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 Italy
10.3.4 Spain
10.3.5 U.K.
10.3.6 Rest of Europe (RoE)
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 Australia
10.4.4 India
10.4.5 Rest of Asia-Pacific (RoAPAC)
10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.1.1 Brazil
10.5.1.2 Mexico
10.5.1.3 Rest of Latin America (ROLA)
10.5.2 Middle East & Africa
11 Competitive Landscape
11.1 Overview
11.2 Molecular Diagnostics Market Share Analysis
11.3 Market Competitor Share Analysis, By Application
11.3.1 Market Share Analysis for Blood Screening Applications
11.3.2 Ranking for Microbiology Applications
11.4 Molecular Diagnostics Market Share Analysis, By Technology
11.4.1 Polymerase Chain Reaction (PCR)
11.4.2 DNA Sequencing and NGs
11.4.3 Microarray
11.4.4 Hybridization (In Situ and Fluorescence)
11.4.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
11.5 New Product Launches and Approvals
11.6 Agreements, Collaborations, Partnerships, Joint Ventures, and Contracts
11.7 Acquisitions
11.8 Other Strategies
12 Company Profiles
12.1 Introduction
12.2 Abbott Laboratories
12.3 Qiagen N.V.
12.4 Roche Diagnostics
12.5 Hologic, Inc.
12.6 Grifols
12.7 Siemens Healthcare
12.8 Becton, Dickinson and Company
12.9 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
12.10 Biomérieux Sa
12.11 Cepheid Inc.
The Global Molecular Diagnostics Market has been segmented as below:
By Application Analysis
Infectious Diseases
Genetics
Oncology
Microbiology
Blood Screening
Others
By Product Analysis
Instruments
Reagents
Services & Software
By Technology Analysis
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Hybridization
DNA Sequencing and Next-generation Sequencing
Microarrays
Others (Mass Spectrometry, Flow Cytometry, and Electrophoresis)
By End-user Analysis
Hospital Laboratories
Reference Laboratories
Others
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
